Notably, a 38% reduction in tumor weight was observed following treatment with EGFR × HYAL, whereas no notable change was noted with EGFR × Null, highlighting the specific role of hyaluronidase in remodeling the tumor stroma (Figure 2D). Here, EGFR is linked to neoplasm.